Application of inosine in prevention and treatment of depression
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- SICHUAN CREDIT PHARMA
- Publication Date
- 2018-11-30
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, in particular to the application of inosine in preventing depression. Background technique
[0002] Depression is a heterogeneous major mental illness caused by multiple factors, with significant and persistent low mood as the main clinical feature. Its morbidity and mortality are high. According to the World Health Organization, the global annual incidence of depressive disorder is about 6%, and the lifetime prevalence is about 16%. There are about 350 million depressed patients in the world. The prevalence of depression in my country is about 6.87%, that is, about 90 million people are affected. Long-term persistent depressive symptoms can lead to severe cognitive impairment, which brings a heavy burden of disease to patients, families and society. 50% to 60% of patients with depression are accompanied by suicidal tendencies, and 15% to 20% of patients eventually commit suicide. According ...